In particular, the work by Frisoni et al. [23] concluded that older schizophrenia patients display a peculiar pattern of CSF amyloid and tau biomarkers, mostly related to a neurodevelopmental effect, and not to a neurodegeneration process. This evidence concerns the gene MAPT and schizophrenia.